As exemplified in Figure 1, immunostaining for EYA1 in ganglioneuroma or ganglioneuroblastoma was generally lower (1b and 1c) than was the case for neuroblastoma (P=0.0068; Figure 1b and 1d). This evidence concerns the gene EYA1 and neuroblastoma.